MAPT and supranuclear palsy, progressive, 1: With the exception of these prior studies focused on expression of PSP candidate genes, little is currently known of other transcriptional changes in the human brain that may be implicated in PSP risk and the distinct tau neuropathological lesions observed in this disease.